Sellas Life Sciences Group(SLS)
NEW YORK, NYBiotechnology
Focus: Sellas Life Sciences is a publicly traded oncology-focused biotech developing cancer immunotherapies, primarily peptide vaccines and cell therapies for hematologic malignancies and solid tumors. The company operates at modest scale with a lean R&D footprint centered on early-to-mid stage pipeline advancement.
Profile data last refreshed 1h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Sellas Life Sciences Group
AI assessmentNot HiringNo open roles listed right now. Follow Sellas Life Sciences Group to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Galinpepimut-S
Acute Myeloid LeukemiaClinical Trials (1)
NCT05593185Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
N/AHelp build intelligence for Sellas Life Sciences Group
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.